Publication date: Jan 14, 2020
An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc. , publishers.
Read the special issue on Glycomics and Personalized Glycomedicine free on the OMICS: A Journal of Integrative Biology website until February 15, 2020.
This OMICS special issue on glycomics and personalized glycomedicine signals the rise of glyco-theranostics as a new specialty in diagnostic medicine and systems science.
|disease||MESH||Type 2 Diabetes Mellitus|
- Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer.
- Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.
- Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.